Zai Lab Limited (NASDAQ:ZLAB)

ZLAB is an innovative biopharmaceutical company based in Shanghai focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases therapies. Our mission is to transform patients’ lives in China and eventually leverage our capabilities to impact human health worldwide.

Last updated September 22, 2017


Market Data powered by QuoteMedia. Terms of Use